Income Statement Oiles Corporation

Stocks

6282

JP3174200000

Industrial Machinery & Equipment

Market Closed - Japan Exchange 02:30:00 2026-08-24 EDT			5-day change	1st Jan Change
2,919.00 ^JPY	+0.86%		-1.39%	+24.16%

08-06	Oiles Corporation Revises Consolidated Earnings Guidance for the Six Months Ending September 30, 2026	CI
08-06	Oiles Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI

a362a14682e1eb8af.cFSJekxG58jhdrzsx5J5RYvPnRELrcYXOlSDUGaRdPM.OQ3rHCs0gIXVB_LelcQ9IN6F8lBIz6JtXi3VYT7oQIQBecwMKAGQoLAhiA

Published financial data: OILES CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	59.85B	62.88B	68.76B	67.6B	68.96B
Total Revenues	59.85B	62.88B	68.76B	67.6B	68.96B
Cost of Goods Sold, Total	39.64B	42.97B	45.78B	43.92B	44.82B
Gross Profit	20.22B	19.91B	22.99B	23.68B	24.14B
Selling General & Admin Expenses, Total	13.71B	14.12B	14.9B	15.89B	16.19B
Provision for Bad Debts	7M	4M	2M	6M	66M
Depreciation & Amortization - (IS)	543M	591M	659M	712M	799M
Other Operating Expenses	98M	138M	138M	134M	126M
Other Operating Expenses, Total	14.36B	14.85B	15.7B	16.74B	17.18B
Operating Income	5.86B	5.06B	7.29B	6.94B	6.96B
Interest Expense, Total	-22M	-10M	-9M	-10M	-9M
Interest And Investment Income	297M	375M	365M	405M	373M
Net Interest Expenses	275M	365M	356M	395M	364M
Currency Exchange Gains (Loss)	256M	436M	519M	-221M	72M
Other Non Operating Income (Expenses)	317M	274M	327M	196M	226M
EBT, Excl. Unusual Items	6.71B	6.13B	8.49B	7.31B	7.62B
Gain (Loss) On Sale Of Investments	39M	228M	255M	842M	1.38B
Gain (Loss) On Sale Of Assets	-141M	-28M	-55M	-78M	-81M
Asset Writedown	-196M	-402M	-705M	68M	-382M
Other Unusual Items	-1M	-1M	-	-7M	-1.4B
EBT, Incl. Unusual Items	6.41B	5.93B	7.99B	8.14B	7.14B
Income Tax Expense	2B	1.73B	2.47B	1.81B	2.1B
Earnings From Continuing Operations	4.41B	4.2B	5.52B	6.33B	5.04B
Net Income to Company	4.41B	4.2B	5.52B	6.33B	5.04B
Minority Interest	-83M	-69M	-47M	-20M	-36M
Net Income - (IS)	4.32B	4.13B	5.48B	6.31B	5.01B
Net Income to Common Incl Extra Items	4.32B	4.13B	5.48B	6.31B	5.01B
Net Income to Common Excl. Extra Items	4.32B	4.13B	5.48B	6.31B	5.01B
Per Share Items
Net EPS - Basic	137.56	132.44	177.76	208.38	171.75
Basic EPS - Continuing Operations	137.56	132.44	177.76	208.38	171.75
Basic Weighted Average Shares Outstanding	31.44M	31.2M	30.8M	30.27M	29.16M
Net EPS - Diluted	137.56	132.44	177.76	208.38	171.75
Diluted EPS - Continuing Operations	137.56	132.44	177.76	208.38	171.75
Diluted Weighted Average Shares Outstanding	31.44M	31.2M	30.8M	30.27M	29.16M
Normalized Basic EPS	130.75	120.62	170.81	150.31	162.09
Normalized Diluted EPS	130.75	120.62	170.81	150.31	162.09
Dividend Per Share	50	55	75	85	85
Payout Ratio	37.04	43.85	35.87	37.02	53.64
Supplemental Items
EBITDA	8.84B	8.33B	10.66B	10.41B	10.4B
EBITA	5.86B	5.06B	7.29B	6.94B	6.96B
EBIT	5.86B	5.06B	7.29B	6.94B	6.96B
EBITDAR	9.55B	9.06B	11.47B	11.18B	11.29B
Effective Tax Rate - (Ratio)	31.24	29.14	30.87	22.23	29.34
Normalized Net Income	4.11B	3.76B	5.26B	4.55B	4.73B
Non-Cash Pension Expense	-80M	-56M	-78M	-74M	-4M
Supplemental Operating Expense Items
Advertising Expense	74M	91M	125M	164M	178M
Selling and Marketing Expenses	1.44B	1.39B	1.49B	1.47B	1.49B
Research And Development Expense From Footnotes	2.44B	2.53B	2.53B	2.88B	2.97B
Net Rental Expense, Total	704M	723M	812M	773M	897M
Imputed Operating Lease Interest Expense	21.07M	12.88M	18.8M	33.02M	40.62M
Imputed Operating Lease Depreciation	683M	710M	793M	740M	856M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	21.11B	23.39B	25.31B	25.2B	28.56B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	21.11B	23.39B	25.31B	25.2B	28.56B
Accounts Receivable, Total	19.78B	17.83B	22.57B	19.16B	18.54B
Other Receivables	-	-	-	-	-
Total Receivables	19.78B	17.83B	22.57B	19.16B	18.54B
Inventory	11.34B	12.54B	12.67B	13.36B	12.29B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	933M	1.01B	1.03B	1.59B	991M
Total Current Assets	53.16B	54.77B	61.59B	59.32B	60.38B
Net Property Plant And Equipment	22.91B	22.8B	22.1B	22.99B	25.84B
Long-term Investments	8.8B	8.73B	10.66B	9.58B	11.73B
Other Intangibles, Total	349M	344M	361M	831M	932M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	305M	342M	365M	640M	553M
Other Long-Term Assets, Total	1M	2M	1M	1M	2M
Total Assets	85.53B	86.99B	95.08B	93.36B	99.43B
Liabilities
Accounts Payable, Total	5.9B	6.76B	8.06B	6.12B	5.51B
Accrued Expenses, Total	3.16B	3.14B	3.36B	3.9B	3.95B
Current Portion of Long-Term Debt	1.09B	1.09B	1.09B	1.1B	-
Current Portion of Leases	64M	94M	74M	87M	129M
Current Income Taxes Payable	1.62B	496M	2B	721M	1.36B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	1.28B	1.03B	1.47B	1.58B	2.58B
Total Current Liabilities	13.11B	12.61B	16.06B	13.5B	13.52B
Long-Term Debt	3.89B	2.52B	1.15B	-	1.45B
Long-Term Leases	100M	124M	73M	176M	246M
Pension & Other Post Retirement Benefits	610M	681M	667M	847M	785M
Deferred Tax Liability Non Current	482M	694M	1.2B	1.2B	1.66B
Other Non Current Liabilities	742M	770M	1.03B	801M	1.15B
Total Liabilities	18.94B	17.4B	20.18B	16.52B	18.81B
Common Stock, Total	8.58B	8.58B	8.58B	8.58B	8.58B
Additional Paid In Capital	9.62B	9.62B	9.62B	9.62B	9.73B
Retained Earnings	49.67B	51.99B	53.73B	57.67B	60B
Treasury Stock	-4.81B	-5.5B	-4.52B	-7.74B	-8.28B
Comprehensive Income and Other	2.94B	4.26B	6.84B	8.05B	10.05B
Total Common Equity	66B	68.95B	74.25B	76.18B	80.09B
Minority Interest	588M	640M	645M	661M	523M
Total Equity	66.59B	69.59B	74.9B	76.84B	80.62B
Total Liabilities And Equity	85.53B	86.99B	95.08B	93.36B	99.43B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	31.57M	31.01M	30.76M	29.11M	29.2M
ECS Total Common Shares Outstanding	31.57M	31.13M	30.76M	29.41M	29.2M
Book Value / Share	2.09K	2.21K	2.41K	2.59K	2.74K
Tangible Book Value	65.65B	68.6B	73.89B	75.35B	79.16B
Tangible Book Value Per Share	2.08K	2.2K	2.4K	2.56K	2.71K
Total Debt	5.15B	3.83B	2.39B	1.36B	1.82B
Net Debt	-15.96B	-19.56B	-22.93B	-23.84B	-26.74B
Debt Equivalent of Unfunded Proj. Benefit Obligation	430M	544M	453M	729M	-414M
Debt Equivalent Oper. Leases	5.63B	5.78B	6.5B	6.18B	7.18B
Minority Interest, Total (Incl. Fin. Div)	588M	640M	645M	661M	523M
Inventories - Raw Materials, Total	3.65B	3.73B	3.88B	4.12B	3.68B
Inventories - Work In Process, Total	3.44B	3.97B	4.25B	4.64B	3.95B
Inventories - Finished Goods, Total	4.25B	4.84B	4.54B	4.6B	4.66B
Full Time Employees	2.04K	2.03K	2.06K	2.07K	2.06K
Accumulated Allowance for Doubtful Accounts (Supple)	54M	22M	24M	14M	24M
Order Backlog	13.52B	17.98B	15.54B	17.64B	15.45B

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	6.41B	5.93B	7.99B	8.14B	7.14B
Depreciation & Amortization - CF	2.98B	3.28B	3.36B	3.47B	3.44B
Depreciation & Amortization, Total	2.98B	3.28B	3.36B	3.47B	3.44B
(Gain) Loss From Sale Of Asset	150M	28M	55M	78M	81M
(Gain) Loss on Sale of Investments - (CF)	-38M	-227M	-255M	-842M	-1.38B
Other Operating Activities, Total	-1.24B	-2.37B	-1.4B	-2.87B	-1.83B
Change In Accounts Receivable	-1.51B	2.32B	-4.38B	3.8B	871M
Change In Inventories	-1.31B	-750M	309M	-307M	1.24B
Change In Accounts Payable	353M	662M	1.14B	-1.66B	-752M
Change in Other Net Operating Assets	51M	-880M	374M	-1.02B	1.84B
Cash from Operations	5.85B	7.99B	7.2B	8.77B	10.65B
Capital Expenditure	-2.93B	-2.59B	-1.98B	-3.66B	-5.67B
Sale of Property, Plant, and Equipment	75M	32M	10M	29M	8M
Sale (Purchase) of Intangible assets	-46M	-75M	-87M	-577M	-253M
Investment in Marketable and Equity Securities, Total	-112M	389M	839M	1.62B	1.39B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-125M	47M	48M	134M	54M
Cash from Investing	-3.14B	-2.2B	-1.17B	-2.45B	-4.47B
Long-Term Debt Issued, Total	-	-	-	-	1.63B
Total Debt Issued	-	-	-	-	1.63B
Long-Term Debt Repaid, Total	-1.4B	-1.37B	-1.37B	-1.14B	-1.28B
Total Debt Repaid	-1.4B	-1.37B	-1.37B	-1.14B	-1.28B
Issuance of Common Stock	220M	274M	215M	147M	2.02B
Repurchase of Common Stock	-1M	-1B	-1B	-3.37B	-2.46B
Common Dividends Paid	-1.6B	-1.81B	-1.96B	-2.34B	-2.69B
Common & Preferred Stock Dividends Paid	-1.6B	-1.81B	-1.96B	-2.34B	-2.69B
Other Financing Activities, Total	-576M	-163M	-188M	-186M	-315M
Cash from Financing	-3.36B	-4.07B	-4.31B	-6.89B	-3.1B
Foreign Exchange Rate Adjustments	405M	544M	582M	642M	337M
Miscellaneous Cash Flow Adjustments	1M	-1M	-1M	-1M	-1M
Net Change in Cash	-249M	2.26B	2.29B	74M	3.42B
Supplemental Items
Cash Interest Paid	23M	11M	10M	11M	9M
Cash Income Tax Paid (Refund)	1.26B	2.4B	1.42B	2.89B	1.86B
Levered Free Cash Flow	2.12B	3.9B	4.41B	3.15B	5.23B
Unlevered Free Cash Flow	2.14B	3.91B	4.42B	3.15B	5.24B
Change In Net Working Capital	1.53B	-138M	1.43B	418M	-3.38B
Net Debt Issued / Repaid	-1.4B	-1.37B	-1.37B	-1.14B	353M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	4.41	3.66	5.01	4.6	4.51
Return on Total Capital	5.2	4.35	6.05	5.58	5.42
Return On Equity %	6.83	6.17	7.64	8.34	6.41
Return on Common Equity	6.78	6.12	7.65	8.39	6.41
Margin Analysis
Gross Profit Margin %	33.78	31.66	33.43	35.03	35.01
SG&A Margin	22.9	22.45	21.66	23.51	23.48
EBITDA Margin %	14.77	13.25	15.5	15.4	15.07
EBITA Margin %	9.79	8.04	10.6	10.27	10.09
EBIT Margin %	9.79	8.04	10.6	10.27	10.09
Income From Continuing Operations Margin %	7.36	6.68	8.03	9.36	7.32
Net Income Margin %	7.23	6.57	7.96	9.33	7.26
Net Avail. For Common Margin %	7.23	6.57	7.96	9.33	7.26
Normalized Net Income Margin	6.87	5.98	7.65	6.73	6.85
Levered Free Cash Flow Margin	3.55	6.2	6.42	4.65	7.59
Unlevered Free Cash Flow Margin	3.57	6.21	6.43	4.66	7.59
Asset Turnover
Asset Turnover	0.72	0.73	0.76	0.72	0.72
Fixed Assets Turnover	2.66	2.75	3.06	3	2.83
Receivables Turnover (Average Receivables)	3.18	3.34	3.4	3.24	3.66
Inventory Turnover (Average Inventory)	3.78	3.6	3.63	3.37	3.49
Short Term Liquidity
Current Ratio	4.05	4.34	3.84	4.4	4.46
Quick Ratio	3.12	3.27	2.98	3.29	3.48
Operating Cash Flow to Current Liabilities	0.45	0.63	0.45	0.65	0.79
Days Sales Outstanding (Average Receivables)	114.72	109.15	107.53	112.67	99.78
Days Outstanding Inventory (Average Inventory)	96.53	101.4	100.78	108.19	104.45
Average Days Payable Outstanding	49.99	52.32	59.07	57.99	48.49
Cash Conversion Cycle (Average Days)	161.26	158.24	149.24	162.86	155.74
Long Term Solvency
Total Debt/Equity	7.73	5.51	3.19	1.77	2.26
Total Debt / Total Capital	7.17	5.22	3.09	1.74	2.21
LT Debt/Equity	6	3.8	1.63	0.23	2.1
Long-Term Debt / Total Capital	5.57	3.61	1.58	0.22	2.05
Total Liabilities / Total Assets	22.15	20	21.22	17.69	18.92
EBIT / Interest Expense	266.45	505.7	810.22	694.2	773.22
EBITDA / Interest Expense	401.95	833.3	1.18K	1.04K	1.16K
(EBITDA - Capex) / Interest Expense	268.59	574	963.78	675	525
Total Debt / EBITDA	0.58	0.46	0.22	0.13	0.18
Net Debt / EBITDA	-1.81	-2.35	-2.15	-2.29	-2.57
Total Debt / (EBITDA - Capex)	0.87	0.67	0.28	0.2	0.39
Net Debt / (EBITDA - Capex)	-2.7	-3.41	-2.64	-3.53	-5.66
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.98	5.06	9.36	-1.69	2.01
Gross Profit, 1 Yr. Growth %	17.93	-1.52	15.45	3.04	1.94
EBITDA, 1 Yr. Growth %	48.32	-5.77	27.88	-2.33	-0.12
EBITA, 1 Yr. Growth %	86.75	-13.73	44.2	-4.8	0.24
EBIT, 1 Yr. Growth %	86.75	-13.73	44.2	-4.8	0.24
Earnings From Cont. Operations, 1 Yr. Growth %	72.32	-4.7	31.47	14.58	-20.28
Net Income, 1 Yr. Growth %	71.29	-4.46	32.53	15.19	-20.59
Normalized Net Income, 1 Yr. Growth %	70.43	-8.45	39.81	-13.53	3.89
Diluted EPS Before Extra, 1 Yr. Growth %	70.63	-3.73	34.23	17.23	-17.58
Accounts Receivable, 1 Yr. Growth %	10.83	-9.84	26.59	-15.11	-3.23
Inventory, 1 Yr. Growth %	17.8	10.57	1.08	5.44	-8.04
Net Property, Plant and Equip., 1 Yr. Growth %	3.8	-0.47	-3.08	3.99	12.39
Total Assets, 1 Yr. Growth %	6.1	1.71	9.29	-1.8	6.5
Tangible Book Value, 1 Yr. Growth %	7.24	4.5	7.71	1.97	5.06
Common Equity, 1 Yr. Growth %	7.17	4.47	7.69	2.6	5.13
Cash From Operations, 1 Yr. Growth %	41.34	36.53	-9.9	21.91	21.41
Capital Expenditures, 1 Yr. Growth %	-30.77	-11.62	-23.56	84.56	55
Levered Free Cash Flow, 1 Yr. Growth %	-402.69	83.72	13.19	-28.75	66.32
Unlevered Free Cash Flow, 1 Yr. Growth %	-409.62	82.83	13.15	-28.7	66.17
Dividend Per Share, 1 Yr. Growth %	25	10	36.36	13.33	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.26	8.95	7.19	3.69	0.14
Gross Profit, 2 Yr. CAGR %	0.13	7.77	6.63	9.07	2.49
EBITDA, 2 Yr. CAGR %	7.83	18.22	9.77	11.76	-1.23
EBITA, 2 Yr. CAGR %	11.1	26.93	11.53	17.16	-2.31
EBIT, 2 Yr. CAGR %	11.1	26.93	11.53	17.16	-2.31
Earnings From Cont. Operations, 2 Yr. CAGR %	11.81	28.15	11.94	22.73	-4.43
Net Income, 2 Yr. CAGR %	12.26	27.92	12.52	23.56	-4.36
Normalized Net Income, 2 Yr. CAGR %	14.71	24.91	13.14	9.95	-5.22
Diluted EPS Before Extra, 2 Yr. CAGR %	12.02	28.17	13.68	25.44	-1.71
Accounts Receivable, 2 Yr. CAGR %	4.35	-0.04	6.83	3.66	-9.37
Inventory, 2 Yr. CAGR %	7.53	14.13	5.72	3.24	-1.53
Net Property, Plant and Equip., 2 Yr. CAGR %	4.91	1.64	-1.78	0.4	8.11
Total Assets, 2 Yr. CAGR %	3.47	3.88	5.43	3.6	2.26
Tangible Book Value, 2 Yr. CAGR %	5.37	5.86	6.09	4.8	3.5
Common Equity, 2 Yr. CAGR %	5.3	5.81	6.07	5.11	3.86
Cash From Operations, 2 Yr. CAGR %	-16.01	38.91	10.91	4.8	21.66
Capital Expenditures, 2 Yr. CAGR %	-11.46	-21.78	-17.81	18.77	69.14
Levered Free Cash Flow, 2 Yr. CAGR %	-22.07	135.82	44.21	-10.2	8.86
Unlevered Free Cash Flow, 2 Yr. CAGR %	-21.97	137.92	43.83	-10.18	8.85
Dividend Per Share, 2 Yr. CAGR %	0	17.26	22.47	24.32	6.46
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.83	1.48	9.08	4.14	3.13
Gross Profit, 3 Yr. CAGR %	-1.66	-0.42	10.27	5.42	6.64
EBITDA, 3 Yr. CAGR %	4.55	3.09	21.36	5.58	7.65
EBITA, 3 Yr. CAGR %	5.24	2.12	32.44	5.8	11.23
EBIT, 3 Yr. CAGR %	5.24	2.12	32.44	5.8	11.23
Earnings From Cont. Operations, 3 Yr. CAGR %	4.57	6.01	29.25	12.81	6.29
Net Income, 3 Yr. CAGR %	4.98	6.38	29.44	13.41	6.63
Normalized Net Income, 3 Yr. CAGR %	9.2	6.4	29.69	3.44	7.9
Diluted EPS Before Extra, 3 Yr. CAGR %	4.81	6.5	30.16	14.85	9.05
Accounts Receivable, 3 Yr. CAGR %	1.06	-0.61	8.15	-1.05	1.31
Inventory, 3 Yr. CAGR %	4.21	8.54	9.6	5.63	-0.67
Net Property, Plant and Equip., 3 Yr. CAGR %	4.29	3.08	0.04	0.11	4.25
Total Assets, 3 Yr. CAGR %	2.55	2.88	5.65	2.96	4.56
Tangible Book Value, 3 Yr. CAGR %	4.07	5.08	6.47	4.7	4.89
Common Equity, 3 Yr. CAGR %	3.93	5.02	6.43	4.9	5.12
Cash From Operations, 3 Yr. CAGR %	14.86	-1.24	20.24	14.46	10.07
Capital Expenditures, 3 Yr. CAGR %	-16.8	-11.52	-22.38	7.63	29.8
Levered Free Cash Flow, 3 Yr. CAGR %	11.31	3.72	84.64	14	10.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	11.93	3.64	85.72	13.83	10.26
Dividend Per Share, 3 Yr. CAGR %	0	3.23	23.31	19.35	15.62
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.02	1.27	2.3	2.36	5.42
Gross Profit, 5 Yr. CAGR %	-0.32	-0.98	1.58	3.27	7.09
EBITDA, 5 Yr. CAGR %	3.69	2.2	6.61	6.47	11.76
EBITA, 5 Yr. CAGR %	5.81	0.9	7.71	7.89	17.26
EBIT, 5 Yr. CAGR %	5.81	0.9	7.71	7.89	17.26
Earnings From Cont. Operations, 5 Yr. CAGR %	22.53	2.52	7.46	12.41	14.55
Net Income, 5 Yr. CAGR %	24.16	2.89	7.94	12.95	14.68
Normalized Net Income, 5 Yr. CAGR %	8.63	3.24	10.76	7.81	14.4
Diluted EPS Before Extra, 5 Yr. CAGR %	24.3	2.98	8.27	13.71	16.33
Accounts Receivable, 5 Yr. CAGR %	3.33	-0.76	3.33	1.08	0.77
Inventory, 5 Yr. CAGR %	6.78	8.49	4.81	6.39	5
Net Property, Plant and Equip., 5 Yr. CAGR %	6.1	4.74	1.82	2	3.2
Total Assets, 5 Yr. CAGR %	4.36	3.49	3.69	3.17	4.28
Tangible Book Value, 5 Yr. CAGR %	4	3.72	4.87	4.97	5.27
Common Equity, 5 Yr. CAGR %	3.8	3.58	4.78	5.06	5.39
Cash From Operations, 5 Yr. CAGR %	-1.9	5.45	13.26	1.13	20.81
Capital Expenditures, 5 Yr. CAGR %	7.3	-4.6	-17.2	-0.46	5.99
Levered Free Cash Flow, 5 Yr. CAGR %	-11.84	15.97	23.45	-2.09	49.46
Unlevered Free Cash Flow, 5 Yr. CAGR %	-11.79	15.86	23.74	-2.13	49.98
Dividend Per Share, 5 Yr. CAGR %	0	1.92	8.45	11.2	16.27